Results for tag: "Bronchial Hyperreactivity Drug"

The Bronchial Hyperreactivity Drug market is a subset of the larger Respiratory Drugs market. Bronchial Hyperreactivity Drugs are used to treat asthma and other respiratory conditions that cause bronchial hyperreactivity. These drugs work by reducing inflammation and relaxing the airways, allowing for easier breathing. Commonly prescribed Bronchial Hyperreactivity Drugs include corticosteroids, beta-agonists, and leukotriene modifiers. These drugs are available in both oral and inhaled forms. The Bronchial Hyperreactivity Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., AstraZeneca, Novartis, and Boehringer Ingelheim. Show Less Read more